Fibrobiologics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Hamid Khoja, Chief Scientific Officer of FibroBiologics, Inc., has acquired 298,508 shares and accompanying warrants for approximately $0.5 million in a private placement, increasing his beneficial ownership to 7.5%.